M&R Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$148K Buy
1,501
+301
+25% +$29.7K 0.03% 157
2024
Q2
$111K Hold
1,200
0.03% 169
2024
Q1
$114K Hold
1,200
0.03% 169
2023
Q4
$107K Hold
1,200
0.03% 191
2023
Q3
$87.6K Hold
1,200
0.02% 196
2023
Q2
$99.8K Hold
1,200
0.03% 187
2023
Q1
$91.5K Hold
1,200
0.03% 192
2022
Q4
$99.6K Hold
1,200
0.03% 188
2022
Q3
$95K Hold
1,200
0.03% 190
2022
Q2
$89K Sell
1,200
-500
-29% -$37.1K 0.02% 196
2022
Q1
$152K Hold
1,700
0.03% 165
2021
Q4
$190K Hold
1,700
0.04% 157
2021
Q3
$213K Hold
1,700
0.05% 145
2021
Q2
$230K Hold
1,700
0.05% 144
2021
Q1
$230K Sell
1,700
-15,930
-90% -$2.16M 0.06% 134
2020
Q4
$2.48M Sell
17,630
-435
-2% -$61.2K 0.56% 39
2020
Q3
$2.01M Sell
18,065
-950
-5% -$106K 0.5% 44
2020
Q2
$2.13M Buy
19,015
+13,460
+242% +$1.51M 0.57% 41
2020
Q1
$430K Hold
5,555
0.13% 110
2019
Q4
$528K Hold
5,555
0.12% 120
2019
Q3
$423K Hold
5,555
0.1% 133
2019
Q2
$487K Sell
5,555
-450
-7% -$39.5K 0.11% 125
2019
Q1
$523K Buy
6,005
+1,560
+35% +$136K 0.12% 121
2018
Q4
$318K Sell
4,445
-5,745
-56% -$411K 0.08% 141
2018
Q3
$976K Buy
10,190
+185
+2% +$17.7K 0.21% 91
2018
Q2
$952K Buy
10,005
+1,200
+14% +$114K 0.22% 91
2018
Q1
$772K Buy
8,805
+90
+1% +$7.89K 0.18% 101
2017
Q4
$739K Buy
8,715
+1,025
+13% +$86.9K 0.17% 100
2017
Q3
$665K Hold
7,690
0.16% 104
2017
Q2
$582K Hold
7,690
0.14% 109
2017
Q1
$533K Buy
7,690
+550
+8% +$38.1K 0.13% 115
2016
Q4
$422K Buy
+7,140
New +$422K 0.11% 132